Coming to Terms with the FDA Commissioner
This article was originally published in RPM Report
Executive Summary
The Institute of Medicine thinks FDA needs more stability at the highest level, and thinks a six-year fixed term for the commissioner is a good solution. But FDA's new commissioner doesn't agree.